207 related articles for article (PubMed ID: 15767115)
1. Estimation of pharmacokinetic parameters from non-compartmental variables using Microsoft Excel.
Dansirikul C; Choi M; Duffull SB
Comput Biol Med; 2005 Jun; 35(5):389-403. PubMed ID: 15767115
[TBL] [Abstract][Full Text] [Related]
2. PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel.
Zhang Y; Huo M; Zhou J; Xie S
Comput Methods Programs Biomed; 2010 Sep; 99(3):306-14. PubMed ID: 20176408
[TBL] [Abstract][Full Text] [Related]
3. Use of a simulated annealing algorithm to fit compartmental models with an application to fractal pharmacokinetics.
Marsh RE; Riauka TA; McQuarrie SA
J Pharm Pharm Sci; 2007; 10(2):168-79. PubMed ID: 17706176
[TBL] [Abstract][Full Text] [Related]
4. The back-step method--method for obtaining unbiased population parameter estimates for ordered categorical data.
Kjellsson MC; Jönsson S; Karlsson MO
AAPS J; 2004 Aug; 6(3):e19. PubMed ID: 15760104
[TBL] [Abstract][Full Text] [Related]
5. Monte Carlo simulation of parameter confidence intervals for non-linear regression analysis of biological data using Microsoft Excel.
Lambert RJ; Mytilinaios I; Maitland L; Brown AM
Comput Methods Programs Biomed; 2012 Aug; 107(2):155-63. PubMed ID: 21764476
[TBL] [Abstract][Full Text] [Related]
6. Hyperparameter estimation using stochastic approximation with application to population pharmacokinetics.
Mentré F; Mallet A; Steimer JL
Biometrics; 1988 Sep; 44(3):673-83. PubMed ID: 3203126
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic parameters estimation using adaptive Bayesian P-splines models.
Jullion A; Lambert P; Beck B; Vandenhende F
Pharm Stat; 2009; 8(2):98-112. PubMed ID: 18481279
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the nonparametric estimation method in NONMEM VI.
Savic RM; Kjellsson MC; Karlsson MO
Eur J Pharm Sci; 2009 Apr; 37(1):27-35. PubMed ID: 19159684
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients.
Irtan S; Saint-Marcoux F; Rousseau A; Zhang D; Leroy V; Marquet P; Jacqz-Aigrain E
Ther Drug Monit; 2007 Feb; 29(1):96-102. PubMed ID: 17304156
[TBL] [Abstract][Full Text] [Related]
10. Application of non parametric methods to pharmacokinetic models of the Michaelis-Menten type.
Pereira LM; Maya MT; Morais JA
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():497-500. PubMed ID: 1820929
[TBL] [Abstract][Full Text] [Related]
11. Application of direct search optimization for pharmacokinetic parameter estimation.
Khorasheh F; Sattari S; Gerayeli A; Ahmadi AM
J Pharm Pharm Sci; 1999; 2(3):92-8. PubMed ID: 10953255
[TBL] [Abstract][Full Text] [Related]
12. Experience with NONMEM: analysis of routine phenytoin clinical pharmacokinetic data.
Sheiner LB; Grasela TH
Drug Metab Rev; 1984; 15(1-2):293-303. PubMed ID: 6547663
[TBL] [Abstract][Full Text] [Related]
13. Non-linear mixed-effects pharmacokinetic/pharmacodynamic modelling in NLME using differential equations.
Tornøe CW; Agersø H; Jonsson EN; Madsen H; Nielsen HA
Comput Methods Programs Biomed; 2004 Oct; 76(1):31-40. PubMed ID: 15313540
[TBL] [Abstract][Full Text] [Related]
14. An implementation of the Expectation-Maximisation (EM) algorithm for population pharmacokinetic-pharmacodynamic modelling in ACSLXTREME.
Yates JW
Comput Methods Programs Biomed; 2009 Oct; 96(1):49-62. PubMed ID: 19410328
[TBL] [Abstract][Full Text] [Related]
15. Simulation of complex pharmacokinetic models in Microsoft Excel.
Meineke I; Brockmöller J
Comput Methods Programs Biomed; 2007 Dec; 88(3):239-45. PubMed ID: 17981357
[TBL] [Abstract][Full Text] [Related]
16. Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the concentration time curve in patients receiving concomitant sirolimus or cyclosporine.
Figurski MJ; Nawrocki A; Pescovitz MD; Bouw R; Shaw LM
Ther Drug Monit; 2008 Aug; 30(4):445-55. PubMed ID: 18641543
[TBL] [Abstract][Full Text] [Related]
17. KINFIT: a non linear least-squares computer program for the estimation of pharmacokinetic parameters after intravenous administration.
Kaltenbach ML; Vistelle R
Anticancer Res; 1994; 14(6A):2375-7. PubMed ID: 7825975
[TBL] [Abstract][Full Text] [Related]
18. Mixed-effects modelling of the interspecies pharmacokinetic scaling of pegylated human erythropoietin.
Jolling K; Perez Ruixo JJ; Hemeryck A; Vermeulen A; Greway T
Eur J Pharm Sci; 2005 Apr; 24(5):465-75. PubMed ID: 15784336
[TBL] [Abstract][Full Text] [Related]
19. Minimal experimental requirements for structural identifiability in linear compartmental models. The software 'IDEXMIN'.
Mérino JA; de Biasi J; Plusquellec Y; Houin G
Arzneimittelforschung; 1996 Mar; 46(3):324-8. PubMed ID: 8901159
[TBL] [Abstract][Full Text] [Related]
20. Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R.
Comets E; Brendel K; Mentré F
Comput Methods Programs Biomed; 2008 May; 90(2):154-66. PubMed ID: 18215437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
